- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Triple Negative Breast Cancer in United Kingdom
Total 5734 results
-
Ourotech, Inc.Barts & The London NHS Trust; Imperial College Healthcare NHS Trust; Hampshire... and other collaboratorsRecruitingBreast Cancer | Triple Negative Breast CancerUnited Kingdom
-
Queen Mary University of LondonHoffmann-La Roche; MedSIR; Westdeutsche Studiengruppe GmbH (WSG)Active, not recruitingTriple Negative Breast CancerUnited Kingdom
-
Ourotech, Inc.Barts & The London NHS TrustRecruitingTriple Negative Breast Cancer | Triple Negative Breast NeoplasmsUnited Kingdom
-
PIQUR Therapeutics AGHospital Universitari Vall d'Hebron Research Institute; Institut Català d'Oncologia and other collaboratorsCompletedMetastatic Breast CancerSpain, United Kingdom
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH); MedImmune...TerminatedTriple Negative Breast Cancer | Triple Negative Breast Neoplasms | TNBC - Triple-Negative Breast Cancer | Triple-negative Breast CarcinomaUnited States
-
Hoffmann-La RocheCompletedBreast CancerUnited Kingdom
-
Lytix Biopharma ASICON plc; TheradexCompletedMelanoma | Lymphoma | Cancer | Breast Cancer | Head and Neck Cancer | Triple-Negative Breast CancerUnited Kingdom, France, Norway, Belgium, Italy
-
Gilead SciencesActive, not recruitingTriple-Negative Breast CancerUnited States, United Kingdom, Australia, Hong Kong, Korea, Republic of, Taiwan
-
Melinda TelliPfizer; BioMarin PharmaceuticalCompletedAdvanced Breast Cancer | HER2/Neu Negative | Triple-Negative Breast CancerUnited States
-
Filipa Lynce, MDMerck Sharp & Dohme LLC; Zentalis PharmaceuticalsNot yet recruitingBreast Cancer | Triple Negative Breast Cancer | Breast Cancer Female | HER2-negative Breast Cancer | Hormone Receptor Negative Malignant Tumor Breast TripleUnited States
-
ImmunityBio, Inc.WithdrawnTriple Negative Breast Cancer (TNBC)United States
-
Laura KennedyNational Cancer Institute (NCI)SuspendedBreast Cancer | Triple-negative Breast CancerUnited States
-
Texas Tech University Health Sciences Center, El...RecruitingTriple-negative Breast CancerUnited States
-
NuGenerex Immuno-OncologyMerck Sharp & Dohme LLC; NSABP Foundation IncActive, not recruiting
-
Hoffmann-La RocheCompletedTriple-negative Breast CancerUnited States, Korea, Republic of, Canada, United Kingdom, Belgium, Brazil, Germany, Taiwan, Australia, Japan, Spain, Poland, Italy
-
Puma Biotechnology, Inc.CompletedBreast CancerSpain, United Kingdom, France, United States, Denmark, Hong Kong
-
Priyanka SharmaCompletedTriple-negative Breast CancerUnited States
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
Washington University School of MedicineSusan G. Komen Breast Cancer FoundationCompletedTriple Negative Breast Cancer | Triple Negative Breast Neoplasms | Triple-Negative Breast CancerUnited States
-
The Methodist Hospital Research InstituteCompletedMetastatic Triple Negative Breast CancerUnited States
-
Roswell Park Cancer InstituteAIM ImmunoTech Inc.CompletedEstrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple -Negative Breast Cancer | Anatomic Stage IV Breast Cancer AJCCUnited States
-
Wake Forest University Health SciencesMerck Sharp & Dohme LLC; G1 Therapeutics, Inc.RecruitingMetastatic Triple-Negative Breast CancerUnited States
-
University of Maryland, BaltimoreSyndax PharmaceuticalsTerminatedStage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Triple-negative Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
G1 Therapeutics, Inc.TerminatedBreast Cancer | Breast Neoplasm | Triple-Negative Breast Cancer | Triple-Negative Breast NeoplasmsUnited States, Bulgaria, Croatia, Slovenia, Serbia, Belgium, North Macedonia, Slovakia
-
University of Texas Southwestern Medical CenterGateway for Cancer Research; Celldex TherapeuticsRecruitingMetastatic Triple Negative Breast CancerUnited States
-
Joseph SparanoRecruitingBreast Neoplasms | Breast Diseases | Metastatic Triple Negative Breast CancerUnited States
-
Mridula George, MDRecruitingOCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast CancerTriple Negative Breast Cancer (TNBC)United States
-
University of Alabama at BirminghamGlaxoSmithKline; AbbVie; Breast Cancer Research Foundation of AlabamaActive, not recruitingMetastatic Triple Negative Breast CancerUnited States
-
Case Comprehensive Cancer CenterCompletedMetastatic Triple Negative Breast CancerUnited States
-
Institute of Cancer Research, United KingdomMerck Sharp & Dohme LLC; Cancer Research UK; Astex Pharmaceuticals, Inc.RecruitingCervical Cancer | Triple Negative Breast Cancer | Advanced CancerUnited Kingdom
-
Yale UniversityIovance Biotherapeutics, Inc.CompletedMetastatic Triple Negative Breast CancerUnited States
-
ImmunityBio, Inc.TerminatedAdvanced Triple Negative Breast CancerUnited States
-
Texas Tech University Health Sciences Center, El...SuspendedMetastatic Triple-Negative Breast CancerUnited States
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerFrance, Canada, Israel, Italy, Argentina, Brazil, China, Croatia, Germany, Greece, Slovakia, Turkey, Saudi Arabia, Japan, India, Spain, United States, Czechia, Romania, United Kingdom, Morocco, South Africa, Vietnam, Russian Federation
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Susan G. Komen Breast Cancer FoundationCompletedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
Emory UniversityNational Cancer Institute (NCI)RecruitingBreast Cancer Stage II | Breast Cancer Stage III | Breast Cancer Invasive | Breast Cancer Triple NegativeUnited States
-
George T. BuddUnited States Department of Defense; Anixa Biosciences, Inc.RecruitingResidual Disease | TNBC - Triple-Negative Breast Cancer | Pathologic Stage IIA-IIIC Triple-Negative Breast CancerUnited States
-
Nippon Kayaku Co., Ltd.CompletedAdvanced Solid Tumors | Metastatic Triple Negative Breast CancerUnited States
-
Hoffmann-La RocheCompletedBreast CancerFrance, United States, Spain, United Kingdom, Australia
-
University of Kansas Medical CenterMerck Sharp & Dohme LLCActive, not recruitingTriple-negative Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterSynDevRx, Inc.RecruitingBreast Cancer | Metastatic Triple-Negative Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | TNBC - Triple-Negative Breast CancerUnited States
-
Novartis PharmaceuticalsTerminatedTriple Negative Breast Cancer (TNBC)Netherlands, Spain, Hong Kong, Singapore, Italy, Australia, Israel, Japan, United States
-
Institute of Cancer Research, United KingdomAstraZenecaRecruitingBreast NeoplasmUnited Kingdom
-
Novartis PharmaceuticalsCompletedTriple-negative Breast CancerBelgium, Italy, Japan, Taiwan, United States, Australia, Singapore, Spain, Germany, Korea, Republic of, Argentina, Canada, France, Hungary, Israel, Lebanon, Thailand
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
AstraZenecaActive, not recruitingMetastatic Triple Negative Breast CancerUnited States, Belgium, Italy, Spain, United Kingdom, Canada, Czechia, Poland, France, Korea, Republic of, Germany, Taiwan, Portugal, Netherlands, Ireland
-
Roswell Park Cancer InstituteNot yet recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Unresectable Triple-Negative Breast Carcinoma | Refractory Triple-Negative Breast CarcinomaUnited States
-
Calithera Biosciences, IncCompletedTriple Negative Breast Cancer | TNBC - Triple-Negative Breast CancerUnited States
-
Massachusetts General HospitalGilead SciencesRecruitingTriple Negative Breast Cancer | Invasive Breast Cancer | HER2-negative Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast CancerUnited States